751
Participants
Start Date
June 2, 2017
Primary Completion Date
August 31, 2018
Study Completion Date
September 28, 2018
FMX103 minocycline foam 1.5%
Dosage form description: Foam containing minocycline HCl 1.5%. Once daily application of a sufficient amount of foam to cover the entire face. Estimated maximum is 0.5 g of drug product containing 7.5 mg (1.5% active) of minocycline. Participants will apply a small amount of the drug as a thin layer over all areas of the face. Participants should apply the drug at approximately the same time each day, about 1 hour before bedtime.
Vehicle foam
Dosage form description: Foam containing minocycline vehicle foam. Once daily application of a sufficient amount of foam to cover the entire face. Estimated maximum is 0.5 g of drug product containing 0.0 mg (vehicle) of minocycline. Participants will apply a small amount of the drug as a thin layer over all areas of the face. Participants should apply the drug at approximately the same time each day, about 1 hour before bedtime.
Foamix Investigational Site # 136, New York
Foamix Investigational Site #145, New York
Foamix Investigational Site # 111, Stony Brook
Foamix Investigational Site #157, Saint Clair
Foamix Investigational Site #147, Broomall
Foamix Investigational Site # 141, Jenkintown
Foamix Investigational Site # 129, Yardley
Foamix Investigational Site # 119, Charlotte
Foamix Investigational Site # 106, Greenville
Foamix Investigational Site # 118, Alpharetta
Foamix Investigational Site # 139, Snellville
Foamix Investigational Site # 104, Ormond Beach
Foamix Investigational Site # 121, Sanford
Foamix Investigational Site # 112, Hialeah
Foamix Investigational Site #144, Miami Lakes
Foamix Investigational Site #149, Miami
Foamix Investigational Site #151, Miami
Foamix Investigational Site #154, Sweetwater
Foamix Investigational Site # 142, West Palm Beach
Foamix Investigational Site # 124, West Palm Beach
Foamix Investigational Site #150, Lake Worth
Foamix Investigational Site # 125, Tampa
Foamix Investigational Site # 109, Clearwater
Foamix Investigational Site # 122, Murfreesboro
Foamix Investigational Site # 128, Dublin
Foamix Investigational Site # 101, Bexley
Foamix Investigational Site # 138, New Albany
Foamix Investigational Site # 103, Fort Gratiot
Foamix Investigational Site # 120, Troy
Foamix Investigational Site # 140, Warren
Foamix Investigational Site # 137, Ann Arbor
Foamix Investigational Site # 130, Saint Joseph
Foamix Investigational Site # 133, Omaha
Foamix Investigational Site # 102, Metairie
Foamix Investigational Site # 115, New Orleans
Foamix Investigational Site #159, Houston
Foamix Investigational Site # 108, San Antonio
Foamix Investigational Site # 117, Austin
Foamix Investigational Site # 126, Salt Lake City
Foamix Investigational Site #152, Tucson
Foamix Investigational Site #146, Las Vegas
Foamix Investigational Site #155, Los Angeles
Foamix Investigational Site # 123, Santa Monica
Foamix Investigational Site #143, Northridge
Foamix Investigational Site # 131, Oceanside
Foamix Investigational Site #156, Oceanside
Foamix Investigational Site #153, San Diego
Foamix Investigational Site # 114, San Diego
Foamix Investigational Site # 135, Santa Ana
Foamix Investigational Site # 116, San Luis Obispo
Foamix Investigational Site # 127, Fremont
Foamix Investigational Site # 110, Beverly
Foamix Investigational Site # 107, Brighton
Foamix Investigational Site # 105, Johnston
Collaborators (1)
Premier Research Group plc
UNKNOWN
Vyne Therapeutics Inc.
INDUSTRY